Wound Debridement Industry Helps To Revolutionizing Wound Care With Debridement Techniques

 

 

Global wound debridement industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

The global wound debridement industry was estimated at USD 5.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. 

 

Wound Debridement Market Report Highlights

 

The global wound debridement market size was valued at USD 4.45 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. Furthermore, the increased incidences of injuries such as accidents as road accidents, burns, and trauma events across the globe are also anticipated to drive the market. Additionally, the widening base of the geriatric population and increasing initiatives by governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market.

 

Based on region, North America held the dominant market share of 37.87% in 2022. This supremacy can be attributed to the region's well-developed healthcare infrastructure, growing awareness, and the presence of significant important actors. Additionally, the market for wound debridement is anticipated to be driven by an increase in surgical procedures in the North American area.

 

Enzymatic Wound Debridement Market Report Highlights

 

The global enzymatic wound debridement market size was valued at USD 864.24 million in 2022 and is expected to grow at a CAGR of 6.17% over the forecast period. Market demand is rising owing to an increase in the prevalence of chronic diseases, a high number of accidents, and the introduction of technologically advanced products across the globe. 

 

Various initiatives being undertaken by researchers and major market players to develop technologically advanced products owing to the rising demand for enzymatic wound debridement products globally are anticipated to contribute to the market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for the treatment of chronic and acute wounds and papain-based products have been predominantly used for the treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market.

 

Collagenase-based enzymatic wound debridement product segment held the largest share in 2022. Collagenase-based ointments, creams, and gels are some of the enzymatic debridement products used for the debridement of necrotic tissue from venous leg ulcers, pressure ulcers, burn wounds, & partial-thickness burns. These products enable rapid healing and are also effective in the treatment of diabetic foot ulcers. Collagenase-based enzymatic wound debridement products are easily available and are commonly used by medical professionals. The rising prevalence of pressure ulcers, diabetic foot ulcers, and venous leg ulcers is anticipated to contribute to segment growth.

 

Order your copy of Free Sample of “Wound Debridement Industry Data Book - Wound Irrigation Systems, Enzymatic Wound Debridement, Maggot Debridement Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Maggot Debridement Market Report Highlights

 

The global maggot debridement market size was valued at USD 11.88 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2030. The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the major factors contributing to market growth. 

 

The biobags segment held the largest revenue share in 2022 in the market overall maggot debridement market. The segment is anticipated to witness significant growth over the forecast period. This is owing to the rising prevalence of chronic wounds and an increasing number of surgeries across the globe. Biobags are comparatively safer to use and provide results in 28 days. It is the first contained biosurgical dressing approved by the Food and Drug Administration (FDA).

 

Wound Irrigation System Market Report Highlights

 

The global wound irrigation systems market size was valued at USD 303.84 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030.

 

The demand for wound irrigation systems is on the rise owing to technological advancements, the increasing prevalence of chronic diseases, and the rising number of surgical procedures. The rising prevalence of chronic and acute wounds and the introduction of advanced products are the major factors anticipated to drive the market. 

 

The global increase in the incidence of chronic diseases, such as diabetes, cancer, and other autoimmune diseases, is anticipated to fuel the market growth. Factors such as antimicrobial resistance, adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in the prevalence of non-communicable diseases. According to the International Diabetes Federation, in 2021 there were about 536.6 million diabetes cases globally, the same source stated that the cases are expected to reach 642.8 million by 2030. Therefore, such factors are expected to surge the demand for the product, thereby propelling the market growth. 

 

Competitive Landscape

 

Key players operating in the Wound Debridement Industry are –

• Smith+Nephew
• Integra LifeSciences
• 3M
• Convatec Group PLC
• Gunze Limited
• Mölnlycke Health Care AB

Wound Dressing Industry: Innovative Dressings for Faster Healing

 

Global wound dressing industry data book, pblished by Grand View Research’s is a collection of sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

The global wound dressing industry was valued at USD 61.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2022 to 2030. 

 

Abdominal Pads Report Highlights

 

The global abdominal pads market size was valued at USD 967.9 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The abdominal pad is used as a secondary dressing over a primary dressing such as alginate or hydro fiber and it is made up of highly absorbent material to absorb excess fluid. The market for abdominal pads is anticipated to be majorly driven by the rising cases of burn injuries and the surge in the prevalence of chronic wounds. Moreover, the rise in the number of surgical procedures is further expected to fuel market growth.

 

Burns continue to be one of the most prevalent types of injuries, making up a significant number of trauma cases for hospital emergencies globally, marking a decline in their frequency. Burns also continue to cause high mortality rates and morbidity. According to an article titled, “The Global Macroeconomic Burden of Burn Injuries” published in PRS Journal in October 2021, over nine million people suffer from thermal injuries annually across the world. Among those injured, 90% of mortality occurs in low- and middle-income countries (LMICs). Nearly half of these fatalities take place in the South-East Asian regions with the majority occurring in low and middle-income nations. In India, seven million individuals experience burn injuries annually, resulting in 1.4 lakh fatalities and 2.4 lakh disabled people. Thus, the rising prevalence of burn injuries is fueling the abdominal pads market growth.

 

Medical Adhesive Tapes Report Highlights

 

The global medical adhesive tapes market size was valued at USD 750.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. The rising prevalence of chronic disorders, such as diabetic ulcers, venous leg ulcers, and traumatic wounds, is one of the key factors leading to an increase in the usage of medical adhesive tapes. For instance, according to WHO figures, every year, roughly 1.2 million people die due to vehicle crashes, whereas 20 to 50 million people incur non-fatal injuries.

 

The demand for medical adhesive tapes significantly reduced as a result of the COVID-19 pandemic. Medical adhesive tapes are an essential component of healthcare, but due to an increase in COVID-19 cases, there has been a decline in market demand. Hospitals and clinics were under more pressure to reprofile their patients and give COVID-19 patients priority care as the rate of hospitalization rose. However, players in this industry changed their approaches by deciding to pursue R&D throughout the pandemic and creating cutting-edge technologies to assist in the fight against the virus.

 

Order your copy of Free Sample of “Wound Dressing Industry Data Book - Abdominal Pads, Medical Adhesive Tapes and Super Absorbent Dressings, Medical Tapes & Bandages, Moist Wound Dressing, Surgical Dressing Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Super Absorbent Dressings Report Highlights

 

The global super absorbent dressings market size was valued at USD 99.92 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. The demand for super-absorbent dressings is expected to increase due to an increase in the number of chronic diseases across the globe. For instance, according to the Government of Canada, 44% of Canadian adults have at least one of the ten most common chronic conditions. According to a similar source, 11% of Canadians suffer from diabetes, whereas 8% have cancer. Furthermore, a rise in the geriatric population is one of the major driving factors in the market. For instance, according to the Canadian Institute for Health Information, in 2017, the geriatric population comprised 6.2 million, which was expected to reach 10.4 million by 2037. Therefore, an increase in the number of chronic diseases, along with the growth of the geriatric population, is anticipated to propel the market growth during the forecast period.

 

Super absorbent dressings are designed to minimize the adherence to wounds and manage exudate. These dressings can be used over surgical incisions, burns, lacerations, exudating wounds, or grafts. Thus, an increase in the number of surgical procedures is expected to propel the market growth during the forecast period. For instance, according to OMICS Group Conference, about 51.4 million surgical procedures are carried out in UAE, whereas this number increases to 234 million worldwide. Hence, due to the aforementioned factors, the market is anticipated to grow over the forecast period.

 

Competitive Landscape

Key players operating in the Wound Dressing Industry are –

• 3M
• Paul Hartmann AG
• MiMedx
• Medline Industries
• Smith & Nephew
• ConvaTec Group PLC
• Integra LifeSciences
• B. Braun SE
• Molnlycke Health Care AB
• Brightwake Ltd.
• Lohmann & Rauscher

Weight Loss Procedures Industry To Boom As Of Increasing Incidence Of Obesity Across All Age Groups

 

 

Weight Loss Procedures Industry Data Book Covers Liposuction Surgery, Bariatric Surgery, Non-invasive Fat Reduction Market.

 

Global weight loss procedures industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Weight Loss Procedures market was valued at USD 12.1 billion in 2022 and is growing at a CAGR of 10.9% during 2023-2030. 

 

Liposuction Surgery Devices Market Report Highlights

 

The global liposuction surgery devices market size was valued at USD 5.4 billion in 2022 and is growing at a CAGR of 12.6% during 2023-2030, according to a new report by Grand View Research, Inc. The rising frequency of men and women who want to be in proper shape and reduce & remove excess fat from their bodies has led to high demand for liposuction surgeries thus driving the Liposuction surgery market. The liposuction procedure is gaining popularity due to the positive influence garnered by it on social media and the scope of better outcomes while reducing costs & minimizing health risks. The growing trend of noninvasive cosmetic procedures and liposuction is expected to witness significant demand. The field of liposuction has observed many new developments based upon advancements in technology, such as ultrasonic-assisted liposuction, Vaser, Smart Lipo laser-assisted liposuction, Slim Lipo, and PAL power-assisted liposuction.  

Bariatric Surgery Devices Market Report Highlights

The global bariatric surgery devices market was valued at USD 5.2 billion in 2022 and is expanding at a CAGR of 7.4% during 2023-2030, according to a new report by Grand View Research, Inc. Factors such as the high obesity rate, the presence of global players, and approvals by the government for non-invasive surgeries are expected to propel the market growth. Obesity is caused due to unhealthy eating habits and physical inactivity. Obesity is increasing not only in the adult population but also in people under 18 years of age. This is owing to physical inactivity, sitting for hours in front of the TV, playing video games, and no outdoor games. In the case of eating habits, people have more inclination towards fast food rather than healthy food. The high prices of bariatric surgeries in the U.S. have increased medical tourism outside the U.S. and in developing countries such as Mexico and India.

Order your copy of Free Sample of “Weight Loss Procedures Industry Data Book - Liposuction Surgery, Bariatric Surgery, Non-invasive Fat Reduction Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Non-invasive Fat Reduction Market Report Highlights

The global non-invasive fat reduction market size was valued at USD 1.5 billion in 2022 and is growing at a CAGR of 14.6% during 2023-2030, according to a new report by Grand View Research, Inc. The rising involvement of market players in developing and introducing innovative technologies is driving the non-invasive fat reduction market. Other factors like increasing awareness, surging obese population, rise in disposable income, change in lifestyle due to globalization, and increasing demand for fat reduction treatment are expected to boost the market growth. According to the statistics of The Aesthetic Society, non-surgical procedures increased by 44% in 2021. Non-invasive treatments are rapidly replacing invasive surgeries. People are opting more for aesthetic procedures such as skin rejuvenation, fat reduction, and body contouring as the risk associated with these treatments are minor and are gaining a lot of spotlight through various digital platforms.

 

Competitive Landscape

Key players operating in the Weight Loss Procedures Industry are –

• Long Island Plastic Surgical Group
• Nazarian Plastic Surgery
• Piedmont Plastic Surgery & Dermatology
• Anadolu Medical Center
• Quirónsalud Madrid University Hospital
• Hermes Clinics
• The Ageless Clinic
• Manipal Hospitals
• Apollo Hospitals
• Hospital Samaritano de Sao Paulo
• Center of Plastic Surgery & Rehabilitation
• Passy Clinic
• Your Lipo
• NMC Royal Hospital, Khalifa City
• Burjeel Specialty Hospital, Sharjah

Veterinary Rehabilitation Services Industry | Rehab Is Bringing Animal Wellness To New Heights

 

 

Veterinary Rehabilitation Services Industry Data Book Covers Companion Animal, Livestock, Wildlife Animal Market.

 

Global veterinary rehabilitation services industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

The global market size for veterinary rehabilitation services (companion, livestock, & wildlife) was estimated at USD 792.4 million in 2022 and is anticipated to increase at a CAGR of 11.69% from 2023 to 2030.

Companion Animal Rehabilitation Services Market Report Highlights:

 

The global companion animal rehabilitation services market size was valued at USD 499.7 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 11.42% from 2023 to 2030. Based on animal type, the market is segmented into dogs, cats, and others. The advancing pet humanization trends, significant pet ownership rates, and an increasing number of surgical admissions for several pet disease conditions, coupled with post-surgery rehab services referred by veterinarians, are some of the key factors driving the market. Furthermore, the growing penetration of pet insurance in developed & developing countries is contributing to substantial market growth.

 

In addition, the increasing number of organizations recruiting volunteer animal rehabilitators is further boosting the market growth. For instance, ‘our companion-animal rescue & sanctuary organization’ in the U.S. offers two different ways for the general public to volunteer in rehabilitating stray companion animals. Furthermore, the increase in training programs for pet rehabilitation and its wide traction among veterinary practitioners and therapists are further unveiling new opportunities in the market. For instance, the American Association of Rehabilitation Veterinarians states that physical rehabilitation is a rapidly growing field in the veterinary industry with growing educational opportunities.

 

Livestock Animal Rehabilitation Services Report Highlights

 

The global livestock animal rehabilitation services market size was valued at USD 151.93 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.87% from 2023 to 2030. The market is primarily driven by the rising livestock population in developing countries, growing awareness about the benefits of rehabilitation modalities in livestock medical treatments, and increasing adoption of physical therapy among injured farm animals to accelerate healing. In addition, government-sponsored livestock rehabilitation organizations and foundations are increasing in developing regions, which further propels the growth of the market.

 

As per an analysis report published by the Woodland Park Zoo, certain livestock species, such as goats, are often given exercise therapies such as weight shifting and stretching to heal soreness. The warm or hot water floatation therapies are considered an ideal rehabilitation for cows that have damaged limbs or traumatic injuries. The buoyancy of the water enables animals to support their body weight, thereby enhancing easy movements with relatively lesser pain. To promote mobility & rapid wound healing in small livestock species, underwater treadmills are used in rehabilitation centers.

 

North American region dominated the livestock animal rehabilitation services industry with the largest revenue share of around 30% in 2022. The substantial share is attributed to the large presence of licensed veterinary rehabilitators, the increasing number of veterinary hospitals, farm sanctuaries, & rehab centers, advancing veterinary care services, and the rising adoption of physical therapies for farm animals.

 

Order your copy of Free Sample of “Veterinary Rehabilitation Services Industry Data Book - Companion Animal, Livestock, Wildlife Animal Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Wildlife Animal Rehabilitation Services Market Report Highlights

 

The global wildlife animal rehabilitation services market size was valued at USD 140.78 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.43% from 2023 to 2030. With the growing number of people valuing wildlife conservation, the number of volunteer rehabilitators who rescue and protect wounded/injured wildlife animals is also increasing. For instance, according to a study published in March 2022, by the National Library of Medicine, millions of native animals are rescued, rehabilitated, and protected by wildlife rehabilitators each year globally.

 

As the rate of extinction of numerous wild species is accelerating, several countries are increasing their wildlife rescue and rehab facilities, more importantly, to protect endangered species. For instance, Victoria State Government, Australia, grants USD 230,000 for the country’s wildlife rehabilitators as per Wildlife Rehabilitator Grants 2022-30 program. As per the grant, each rehabilitator applicant who holds a valid authorization from the DELWP (Department of Environment, Land, Water, and Planning) is funded up to USD 3,000. Such supportive initiatives by the government are anticipated in boosting the growth of the market. 

 

Competitive Landscape

 

Veterinary rehabilitation hospitals and centers are routinely implementing strategic measures such as advancing their infrastructure with newer therapeutic instruments and launching novel service offerings for various animal species.

Key players operating in the Veterinary Rehabilitation Services Industry are –

• BARC
• Essex Animal Hospital
• Blue Springs Animal Rehabilitation Center
• Triangle Veterinary Referral Hospital

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

The Skin Disease Treatment Industry Takes Center Stage From Niche To Mainstream

 

 

Skin Diseases Treatment Industry Data Book Covers Actinic Keratosis Treatment, Atopic Dermatitis, Alopecia and Acne Drugs Market.

Global skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.

 

Actinic Keratosis Treatment Market Analysis & Forecast

 

The global actinic keratosis (AK) market was valued at USD 6.42 billion in 2022 and is anticipated to witness growth at a rate of 4.20% over the forecast period. Untapped opportunities, the growing prevalence of atopic dermatitis, and the rise in adoption of biologics are anticipated to propel the market growth over the forecast period.

 

Moreover, ongoing product approvals and a surge in product launches are other factors contributing to market growth. For instance, in February 2021, Almirall launched its topical AK treatment in the U.S. In addition, hospitals such as Mount Sinai, Metro East Dermatology, and Skin Cancer Center, among others, offer multiple treatment options for AK. For instance, Mount Sinai group of hospitals offers cryosurgery, topical therapy, chemical peels, and PDT for its management.

 

According to the American Academy of Dermatology Association, more than 40 million Americans develop AK each year and according to the NEWS Medical, the overall rate of AK in the U.S. is estimated to be about 26.5% in males and 10.2% in females. Thus, the prevalence of the disease is higher in men as compared to women. In addition, according to Skin Cancer Foundation, around 58 million Americans have one or more AK. This is the most common precancerous condition to occur on the skin damaged by UV rays. Solar keratosis is an alternative name for AK. If it is not treated in time, then it can develop into SCC, a common type of skin cancer, and it is estimated that around 5% to 10% of AK can develop into SCC.

 

Atopic Dermatitis Market Analysis & Forecast

 

The global atopic dermatitis market was valued at USD 14.19 billion in 2022 and is anticipated to witness growth at a rate of 8.70% over the forecast period. Untapped opportunities, the growing prevalence of atopic dermatitis, rise in the adoption of biologics are anticipated to propel the market growth over the forecast period.

 

Continuous itching of the skin has heightened the adoption rate of topical ointments and creams. For instance, as per the National Eczema Association, 85.8% of people suffering from the condition report daily itching, which makes the adoption of fast-acting topical agents more likely when compared to oral drugs. Increased frequency of hand-washing has increased the appearance of dry and cracked skin in atopic dermatitis patients making them susceptible to infections. The increased number of hand eczema cases is creating an opportunity for the market players to develop ointments and creams with moisturizer bases to capture this untapped opportunity.

 

Topical corticosteroids are the first-line treatment for Atopic Dermatitis (AD). They work by mimicking natural hormones in the body and suppressing the immune system. Corticosteroids are available in various potencies and administered on the basis of the severity of the disease. The introduction of biologics has caused a paradigm shift in the therapeutic setting for AD. Biologics was the largest revenue-generating segment, which is attributed to increased penetration and high usage of the FDA-approved drug Dupilumab. The novel mechanism of target specificity provided the drug offers it a competitive edge in the market. Furthermore, the high price of this drug is likely to accelerate segment growth. However, the others segment is anticipated to witness the highest growth over the forecast years owing to the presence of JAK inhibitors in the pipeline.

 

Order Free Sample Copy of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” published by Grand View Research

 

Alopecia Market Analysis & Forecast

 

The global alopecia market was valued at USD 8.19 billion in 2022 and is anticipated to witness growth at a rate of 8.74% over the forecast period. The significant growth rate can be attributed to the increased number of patients opting for dermatological drugs for the treatment of alopecia and the increasing interest of major pharmaceutical giants in the development and commercialization of novel drugs.

 

In June 2022, FDA approved baricitinib for the treatment of alopecia areata severe cases. Prior to the approval, the treatment was limited to the areas of hair loss, which limited the treatment scope. Smaller players such as Concert Pharmaceuticals are focusing only on developing treatments for alopecia with two successful phase III trials and the drug is projected to launch between 2023-2024. Unmet need and huge revenue generation opportunity is attracting players to the market.

 

The growing prevalence of alopecia is one of the crucial factors driving market growth. As per the American Hair Loss Association, it was stated that over 95% of hair loss in males is triggered by androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. Based on the report published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85.

 

Acne Drugs Market Analysis & Forecast

The global acne drugs market size was valued at USD 8.43 billion in 2022 and is anticipated to witness growth at a rate of 4.74% over the forecast period. The rising importance of aesthetics among the population, unhealthy lifestyle, and increased preference for pharmaceutical drugs over OTC cosmeceutical treatments is driving the market growth.

 

Acne impacts as many as 85% of the population aged 12-24 years and the number is as high as 50 million each year in the U.S. The global prevalence rate for acne is 9.4% which creates a high demand for acne-associated therapeutic products. The Pandemic hampered market growth for acne drugs attributable to limited access to dermatologists, thereby leading to a significant decline in the number of patients receiving prescription drugs. However, the number of patients increased post-pandemic with the rise in patient visits.

 

High demand for over the counter and topical treatments is significantly influencing the market growth with an increase in awareness regarding the usage of pharmaceutical products. The escalating number of competitors focusing on the launch of products in the segment is intensifying the competition. For instance, in March 2022, Galderma announced the launch of an acne vulgaris treatment topical cream. The prescription of a multi-step regimen is common for acne; however, this drug allows once-daily treatment, thus making its adoption easier.

Go through the table of content of skin diseases treatment industry data book to get a better understanding of the Coverage & Scope of the study.

Key players operating in the skin diseases treatment industry are –

• Pfizer Inc.
• AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• GSK plc.
• Amgen Inc.
• Eli Lilly and Company
• UCB
• Novartis AG
• Johnson & Johnson
• Galderma S.A
• AstraZeneca plc

In Vitro Diagnostics And IVD Quality Control Industry Trends and Innovation: Guiding the Future

 

 

In vitro diagnostics and IVD quality control industry data book covers in vitro diagnostics (IVD) and IVD quality control market.

 

Global In Vitro Diagnostics and IVD quality control industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in two reports and one sector report overview.

 

In Vitro Diagnostics (IVD) Market Analysis & Forecast

 

The global in vitro diagnostic market size was valued at USD 111.67 Billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2 % from 2022 to 2030. IVD renders accurate & effective results and has indispensable applications in the field of disease diagnosis. Eventually, quality control services have become requisite in accredited medical or clinical laboratories. In vitro diagnostics shows significant potential for growth driven by an aging global population that requires accurate diagnosis, increased demand for targeted cancer therapies supported by Companion Diagnostic (CDx) devices, and rising demand for infectious diseases diagnostics due to frequent viral/bacterial outbreaks such as COVID-19.

 

In addition, NGS-based genetic prenatal tests are becoming more common, and adoption of these tests is rising due to their low false-positive rates. Hence, FDA recently issued guidance to improve oversight of test quality, accuracy, safety, and medical benefit. Key players such as Illumina, Inc. have NGS-based prenatal screening tests that allow detection of common abnormalities like Down syndrome. Furthermore, the number of people suffering from congenital heart disease is increasing, requiring medical professionals to develop IVD tools for accurate diagnoses. According to CDC, congenital heart defects are the most common birth defects in the U.S., affecting approximately 1% of births every year.

 

The use and demand of Point-of-Care (PoC) tests and devices are rising owing to increased demand for rapid identification of diseases in close proximity to patients to facilitate faster decision-making. This trend is pushing manufacturers to launch small, transportable, fast, and easy-to-use instruments, making use of these instruments easier in non-laboratory settings. For instance, in July 2021, QuantuMDx announced the launch Q-POC system, which offers rapid PoC molecular diagnostics advantageous for settings, such as ICUs, clinics, and birthing centers.

 

IVD Quality Control Market Analysis & Forecast

 

The global in vitro diagnostics quality control market size was estimated at USD 1.12 Billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 2.0% from 2022 to 2030. In IVD quality control, immunochemistry led the global market in 2021 and accounted for a revenue share of more than 35.00%. Key applications of the immunochemistry include detection of infectious microorganisms, such as viruses, bacteria, and fungi, by detecting the presence of their toxins and coat antigens.

 

Diagnostics laboratories are in demand owing to the increasing prevalence of diseases such as infectious diseases, cardiovascular conditions, and diabetes. To meet the industry demand, many private and public laboratories are undergoing accreditation procedures, which is creating a surge for IVD quality control measures. As of May 2022, the quality standards of 330,000 laboratories in the U.S. are regulated under the Clinical Laboratory Improvement Amendments (CLIA) by the CMS, making quality management crucial.

 

Order Free Sample Copy of “In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030” published by Grand View Research

 

Key players operating in the In Vitro Diagnostics And IVD Quality Control Industry are –

• ABBOTT
• BIOMÉRIEUX SA
• BIO-RAD LABORATORIES, INC.
• BECTON, DICKINSON AND COMPANY
• SIEMENS HEALTHINEERS AG
• QIAGEN
• QUIDEL CORPORATION
• F. HOFFMANN-LA ROCHE LTD.
• SYSMEX CORPORATION
• CHARLES RIVER LABORATORIES
• QUEST DIAGNOSTICS
• AGILENT TECHNOLOGIES, INC.
• DANAHER CORPORATION
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Sero AS.
• Sun Diagnostics, LLC
• Ortho Clinical Diagnostics, Inc.
• Randox Laboratories Ltd
• Helena Laboratories Corporation
• SeraCare Life Sciences, Inc.
• Technopath Clinical Diagnostics

Clinical Trial Recruitment Industry- Human Touch Of Finding People For Medical Research

 

 

Global clinical trial recruitment industrydata book is a collection of market sizing information & forecasts, legal authorizations, payout/reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Clinical Trial Patient Recruitment Market Analysis & Forecast

 

The global patient recruitment market generated over USD 780 million revenue in 2021 and is projected to expand at a CAGR of around 8.0% during the forecast period. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market. However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient’s visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.

 

However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021. Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market. With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.

 

Access the Global Clinical Trial Recruitment Industry Data Book from 2023 to 2030, compiled with details by Grand View Research 

 

Clinical Trial Site Management Organization Market Analysis & Forecast

 

The global clinical trials site management organizations market size was valued at USD 4,792.5 million in 2021 and is anticipated to expand at a CAGR of 5.8% from 2022 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market.

 

Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time.

 

Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021.

 

Clinical Trial Support Services Market Analysis & Forecast

 

The global clinical trials support services market was valued at USD 10,124 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain to a severe extent in 2020. However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research.

 

Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail to recruit enough participants, 80% are delayed due to recruiting challenges, and the rate of dropout of participants is increasing. However, to overcome this, a patient retention strategy that is engaging and gives clarity is required. It is critical to ensure that the informed consent materials are simple to grasp. According to a CISCRP study, 35% of trial participants who later dropped out stated that informed consent was difficult to comprehend. An average American is 7th to 8th grade educated, and it is critical to guarantee and analyze the material’s readability before submitting it to the Institutional Review Board (IRB).

 

Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies to streamline their clinical research services. According to the latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements to speed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action to streamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations.

 

Order Free Sample Copy of Clinical Trial Recruitment Industry Data Book, published by Grand View Research 

 

Key players operating in the clinical trial recruitment industry are –

• Antidote
• Clara Health
• Clariness
• BBK Worldwide
• Worldwide Clinical Trials
• Clinical Site Services (CCSi)
• IQVIA
• PPD Inc
• Veristat
• Elligo Health Research
• Charles River Laboratories Inc.
• Eurofins Scientific SE
• Syneos Health Inc.
• The Pharmaceutical Product Development LLC
• Icon PLC
• WuXi AppTec
• LabCorp
• Alcura
• Parexel International
• Clinedge
• WCG
• ClinChoice
• Access Clinical Research
• FOMAT Medical Research INC.
• SGS
• KV Clinical
• SMO-Pharmina
• Xylem Clinical Research
• Aurum Clinical Research

Male Infertility Industry: Unveiling And A Growing Market With Evolving Solutions

 

 

Global male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

 

Male Infertility Diagnosis Market Analysis & Forecast

 

The global male infertility diagnosis market size was valued at USD 343.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030. A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes. Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm. It can also lead to erectile dysfunction and decreased libido.

 

Smoking can also affect the success rate of ARTs, such as IVF. Thus, as a result of the abovementioned factors, the increasing incidence of infertility is expected to help the market grow. Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology.

 

Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period. The manual method is still widely used for semen analysis in developing economies. However, this method is expected to be replaced by computer-assisted semen analysis in the coming years.

 

Access the Global Male Infertility Industry Data Book from 2023 to 2030, compiled with details by Grand View Research

 

Male Infertility Treatment Market Analysis & Forecast

 

The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030. High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone.

 

In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period. Drugs and hormonal therapy are preferred for initial treatment. ART is usually preferred in case treatment with medication fails.

 

Furthermore, advancements in technology and techniques have significantly improved the success rate of ART procedures. For instance, the use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period.

 

Male Infertility Market – Global Industry Segmentation

 

Male Infertility Diagnosis Market (Revenue, USD Million, 2018 - 2030)

• Technique
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Sperm Penetration Assay
• Others

 

Male Infertility Treatment Market (Revenue, USD Million, 2018 - 2030)

• Type
• ART and varicocele surgery
• Medication

 

Male Infertility Industry, By Region (Revenue, USD Million, 2018 - 2030)

• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o India
o Japan
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait

 

Order Free Sample Copy of Male Infertility Industry Data Book, published by Grand View Research

 

Key players operating in the male infertility industry are –

• EMD Serono, Inc.
• Endo International plc
• Sanofi
• Bayer Group
• SCSA Diagnostics
• Halotech DNA SL
• Intas Pharmaceuticals Ltd.
• Aytu BioScience, Inc.
• Cadila Pharmaceuticals
• Vitrolife

Surgical Robots Industry - Impact on Patients, Surgeons, and the Healthcare

 

 

Surgical Robots Industry Data Book Covers Orthopedics and Non- Orthopedics Market. The global surgical robots market was valued at USD 3.5 Billion in 2022 and is anticipated to grow at a CAGR of 18.0 % over the forecast period.

 

Global surgical robots industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a surgical robots statistics e-book.

 

Access the Global Surgical Robots Industry Data Book from 2023 to 2030, compiled with details by Grand View Research

 

Orthopedics Market Analysis & Forecast

 

The global orthopedics market was valued at USD 805.7 million in 2022 and is anticipated to grow at a CAGR of 12.8% over the forecast period. The growth is attributed to the increasing prevalence of orthopedic conditions, such as degenerative bone disease, the growing geriatric population, and an increasing number of accidents. According to a study conducted by WHO, around 80% of the geriatric population lives in middle and low-income nations. This is anticipated to create a huge opportunity for key players in the market to expand their presence in emerging nations.

 

Moreover, the early onset of musculoskeletal problems, mostly caused by a sedentary lifestyle and obesity, is expected to drive market expansion. Musculoskeletal diseases affect around 1.71 billion people globally, according to the Global Burden of Disease in 2021. As a result, an increase in musculoskeletal problems is expected to drive the market over the forecast period. Additionally, growing awareness regarding the availability of innovative items is causing hospitals to improve their technology and services frequently. Furthermore, payment coverage for orthopedic therapies has contributed to the adoption of orthopedic procedures.

 

Prominent players in the market are adopting strategies such as acquisitions, collaborations, new product launches, and expansions to strengthen their market position. For instance, in May 2023, Zimmer Biomet Holdings, Inc. announced the acquisition of OSSIS, a medical company specializing in customized 3D-printed implants and complex hip replacements. This acquisition is expected to enhance Zimmer Biomet’s capabilities in providing technologically advanced personalized orthopedic solutions.

 

Non-Orthopedics Market Analysis & Forecast

 

Non-Orthopedic applications of surgical robots include robots for neurology, cardiology, gynecology, urology, and others. The global non-orthopedic market was valued at USD 2.74 billion in 2022 and is anticipated to grow at a CAGR of 19.2% over the forecast period. The growth is attributed to the increasing prevalence of neurological disorders coupled with the rising number of road accidents causing brain injuries. According to the International Brain Injury Association, around one million traumatic brain injuries are treated in the United States every year. Additionally, around 80,000 patients are discharged from hospitals with traumatic brain injury disability.

 

Furthermore, technological advancements in the field of neurology, urology, and gynecology have eliminated direct human involvement in surgical operations. These devices are reducing the downsides of invasive procedures. Data recorders, HD microscopic cameras, remote navigation systems, motion sensors, transducers, and robotic-controlled catheters are among the most recent advancements. The major market participants are investing much in R&D to develop technologically advanced medical devices. For example, Brain Scientific, Inc. will deliver the next-generation NeuroCap device in March 2021. It is an advanced EEG electrode array that is utilized in clinical and research settings to deliver quick EEGs whenever required. This is anticipated to drive market growth in the coming years.

 

Furthermore, the increasing prevalence of high blood pressure and diabetes is also contributing to the rising demand for efficient and technologically advanced urology solutions. According to data published by the American Kidney Fund, around 25% of kidney failures are caused due to high blood pressure, and around 38.4% of kidney conditions are caused due to diabetes. The aforementioned factor is anticipated to drive the market demand over the forecast period.

 

Moreover, key players in the market are acquiring new players in the market to strengthen their market share and expand to untapped markets. In addition, market players are investing in R&D for the development of technologically advanced solutions. In September 2021, NovaSignal Corp. announced the closing of a USD 31 million Series C1 funding round. The company will use the resources for its commercial expansion, and development of innovative products.

 

Order Free Sample Copy of "Surgical Robots Industry Data Book - Orthopedics and Non- Orthopedics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research 

 

Key players operating in the surgical robots industry are –

 

• Stryker
• Medrobotics
• Smith+Nephew
• TransEnterix Surgical, Inc.
• Renishaw plc.
• Intuitive Surgical
• Medtronic
• THINK Surgical, Inc.
• Zimmer Biomet

The Spectrometry Industry: Driving Innovation In Healthcare, Manufacturing, And Environmental Protection

 

 

Global Spectrometry Industry databook is a collection of market sizing & forecast insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

 

Spectrometry Market Insights

 

The global spectrometry market size was estimated at USD 17.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.34% from 2022 to 2030. The market is expected to expand at a CAGR of 7.2% from 2021 to 2028. Key players offer technologically advanced spectrometry products for several healthcare applications and have collaborated with research institutes to develop novel products.

 

The market is expected to show potential growth in the coming future owing to the introduction of healthcare services using MALDI-TOF mass spectrometry (MS) by key players operating in the market. For instance, in November 2020, Shimadzu Corporation launched the Amyloid MS service for the early diagnosis of amyloid-positive patients in the U.S. The analysis of blood is performed using a combination of MALDI-TOF MS (IP-MS) and immunoprecipitation.

 

Access the Global Spectrometry Industry Data Book from 2023 to 2030, compiled with details by Grand View Research

 

Mass Spectrometry Market Insights

 

The global mass spectrometry market size was valued at USD 5.83 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.87% from 2022 to 2030. Rising awareness regarding early detection of chronic and infectious diseases and emerging technological advancements in diagnostic instruments are expected to significantly drive the market growth. In addition, there has been an increase in demand for cost-effective and automated techniques for disease diagnosis which is anticipated to increase the demand for mass spectrometry techniques and positively affect the growth.

 

The COVID-19 pandemic has boosted the demand for vaccine development due to recent advancements in virology-based research. Here, mass spectrometry has applications for the study of viral structure for SARS-CoV-2. The technique can also be used to study complex protein structures and protein-protein interactions associated with the virus. Hence, various pharmaceutical and biotechnology companies involved in COVID-19 vaccine and drug development efforts are anticipated to increase the demand for instruments and consumables.

 

NMR Spectroscopy Market Insights

 

The global nuclear magnetic resonance spectroscopy market size was valued at USD 657.11 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030. The market is anticipated to expand at a CAGR of 5.1% from 2023 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

 

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW–Madison’s National Magnetic Resonance Facility at Madison.

 

Near-Infrared Spectroscopy Market Insights

 

The global near-infrared spectroscopy market size is expected to reach USD 453.72 million in 2021, registering a CAGR of 6.08% over the forecast period, according to a new report by Grand View Research, Inc. The growing implementation of an analytical technique for raw materials in numerous sectors, such as oil & gas and agriculture, coupled with their increasing applications is anticipated to spur industry growth. For instance, various herbs and plants with therapeutic and medicinal properties are analyzed through near-infrared (NIR) spectroscopy to assess the bio-active components. The industry has witnessed considerable growth in 2021 and is expected to have similar developments during the forecasted period.

 

The demand for the products from the material science sector is a substantial contributor to the revenue. NIR spectrometry provides significant advantages as a process analytical technology over other techniques including wet chemical methods, resulting in increasing preference from manufacturers. Other determinants, such as rapid advancement in the workflows of material verification, as well as improving risk management in the supply chain by manufacturers to fulfill the GMP criteria, are also contributing to the growth. The major 20 pharmaceutical manufacturers employ portable NIR analyzers to authenticate either raw materials or finished products to comply with GMP guidelines. Similarly, regulatory bodies in Europe, North America, Africa, and Asia have purchased the product to strengthen their counterfeiting efforts.

 

Order Free Sample Copy of Spectrometry Industry Data Book, published by Grand View Research

 

In-line UV-vis Spectroscopy Market Insights

 

Notable technological advancements in the UV-vis spectroscopic method have accelerated the in-line monitoring of compounds using UV-vis-spectrometry across various fields, such as environmental monitoring, materials science, pharmaceutical research, and agriculture. The introduction of advanced solutions, such as enhanced silicon and InGaAs detectors & Light-emitting Diode (LED) sources, have supported the adoption of this UV-Vis spectroscopy technique, thereby driving the industry.

 

UV/Visible spectrophotometers are widely used by laboratories, including that associated with academia and governments, as well as other industries. The introduction of multiple regulatory guidelines for effective approval and new product development processes across various industries, such as the pharmaceutical, food & beverages, and cosmetics industries, is anticipated to increase the adoption of products. In the pharmaceutical industry, the introduction of UV-Vis spectrophotometry that operates in compliance with United States Pharmacopeia (USP), Japanese Pharmacopoeia (JP), and the European Pharmacopoeia (EP) is anticipated to drive the industry. 

 

Key players operating in the spectrometry industry are –

• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Waters Corporation
• Shimadzu Corporation
• Bruker Corporation
• JEOL Ltd